di Redazione
Bibliografia del testo pubblicato sul numero 161 de L’altra medicina
Bibliografia
(1)Healy, D., Bahrick, A., Bak, M., Barbato, A., Calabrò, R. S., M, F. C. B., … Waraich, A. (2022). Diagnostic criteria for enduring sexual dysfunction after treatment with Antidepressants, finasteride and isotretinoin. Int. J. Risk Saf. Med., 33, 65–76.
Gül, M., Fode, M., Urkmez, A. et al. A clinical guide to rare male sexual disorders. Nat Rev Urol 21, 35–49 (2024). https://doi.org/10.1038/s41585-023-00803-5
(2)Melcangi, Roberto Cosimo, Santi, D., Roberto, M. S., Grimoldi, Tabacchi, T., Fusco, M. L., … Cavaletti, G. (2017). Neuroactive steroid levels and psychiatric and andrological Features in post-finasteride patients. J. Steroid Biochem. Mol. Biol., 171, 229–235.
(3)Firenzuoli, F., Firenzuoli, B., Mascherini, V., Firenzuoli, N., Menniti-Ippolito, F., Ippoliti, I., Maggini, V., Gallo, E., Cuomo, A., Fagiolini, A., Gensini, G. F., & Firenzuoli, F. (2026). Can we identify a post-Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens. British journal of clinical pharmacology, 10.1002/bcp.70442. Advance online publication. https://doi.org/10.1002/bcp.70442
(4)Boudou, P., Soliman, H., Chivot, M., Villette, J. M., Vexiau, P., Belanger, A., & Fiet, J. (1995). Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic Patients. J. Clin. Endocrinol. Metab., 80, 1158–1161.
(5A) Bremner, J. D., Fani, N., Ashraf, A., Votaw, J. R., Brummer, M. E., Cummins, T., … Nemeroff,C. B. (2005). Functional brain imaging alterations in acne patients treated withIsotretinoin. Am. J. Psychiatry, 162, 983–991.
(5B) O’Reilly, K. C., Trent, S., Bailey, S. J., & Lane, M. A. (2007). 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Experimental biology and medicine (Maywood, N.J.), 232(9), 1195–1203. https://doi.org/10.3181/0703-RM-83
(6) Droitcourt, C., Nowak, E., Caroline, A. R., Happe, Nautout, B. L., Kerbrat, S., … Dupuy. (2019). Risk of suicide attempt associated with isotretinoin: a nationwide cohort andNested case-time-control study. Int. J. Epidemiol., 48, 1623–1635.
(7) Gieler, U., & Gieler, T. (2020). Suicidal risk with isotretinoin treatment – a never-ending story.Journal of the European Academy of Dermatology and Venereology, 34, 1131–1133. Doi:10.1111/jdv.16489
(8) Diviccaro, S., Giatti, S., Cioffi, L., Falvo, E., Piazza, R., Caruso, D., & Melcangi, R. C.(2022b). Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and Microbiota. Psychoneuroendocrinology, 143, 105828.Doi:10.1016/j.psyneuen.2022.105828
(9) Giatti, S., Diviccaro, S., Cioffi, L., Falvo, E., Caruso, D., & Melcangi, R. C. (2021). Effects of Paroxetine treatment and its withdrawal on neurosteroidogenesis.Psychoneuroendocrinology, 132, 105364. Doi:10.1016/j.psyneuen.2021.105364
(10)Abdelhamid, L., & Luo, X. M. (2018). Retinoic Acid, Leaky Gut, and Autoimmune Diseases. Nutrients, 10(8), 1016. https://doi.org/10.3390/nu10081016
(11) Caruso, D., Abbiati, F., Giatti, S., Romano, S., Fusco, L., Cavaletti, G., & Melcangi, R. C. (2015). Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma. The Journal of steroid biochemistry and molecular biology, 146, 74–79. https://doi.org/10.1016/j.jsbmb.2014.03.012
(12) Diviccaro, S., Giatti, S., Cioffi, L., Falvo, E., Herian, M., Caruso, D., & Melcangi, R. C. (2022). Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats. Biomolecules, 12(11), 1567. https://doi.org/10.3390/biom12111567
(13) Vasan, S., & Padhy, R. K. (2023). Tardive Dyskinesia. In StatPearls. StatPearls Publishing.
(14) Stachelek, J., Zwaans, B. M. M., Shtein, R., & Peters, K. M. (2025). Insights into the peripheral nature of persistent sexual dysfunction associated with post-finasteride, post-SSRI and post-accutane syndromes: lessons learned from a case study. International urology and nephrology, 57(8), 2387–2394.
https://doi.org/10.1007/s11255-025-04373-w
(15)Healy, D., Le Noury, J., & Mangin, D. (2018). Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. The International journal of risk & safety in medicine, 29(3-4), 125–134. https://doi.org/10.3233/JRS-180744
